secwatch.observer — SEC 8-K summary
======================================

Issuer:     VOLITIONRX LTD (VNRX)
CIK:        0000093314
Form:       8-K
Filed at:   2025-10-14T23:59:59+00:00
Accession:  0001477932-25-007544
Event type: other_material
Sentiment:  negative
Materiality: 0.80
Item codes: 1.01, 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

VolitionRx raises $6M in underwritten offering; only $0.3M cash pre-offering
----------------------------------------------------------------------------

- Gross proceeds $6.0M from 11.55M units at $0.52; net ~$5.4M after underwriting discounts and expenses.
- Each unit contains one share and one warrant; warrants exercisable at $0.60, 5-year term, cashless basis if no registration.
- Pre-offering cash and cash equivalents estimated at only $0.3M as of September 30, 2025.
- Offering closed October 14, 2025; directors and officers purchased 254,229 units on same terms.
- Proceeds to fund R&D, clinical studies, product commercialization, working capital, and potential strategic acquisitions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/93314/000147793225007544/0001477932-25-007544-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/93314/000147793225007544/vnrx_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-25-007544

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer